AARDVARK THERAPEUTICS
Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders. Aardvark Therapeutics was founded by Tien Lee in 2017.
AARDVARK THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.aardvarktherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
858-225-7696
Total Funding:
44 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API WordPress Content Delivery Network Apache Wordpress Plugins JsDelivr PHP Contact Form 7
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
APRINOIA Therapeutics
Biotechnology, Neuorscience
Atrapos Therapeutics
Atrapos Therapeutics specializes in developing therapeutic solutions for auto-immune disorders.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Azafaros
Azafaros aims at developing new therapeutic agents for the treatment of rare metabolic disorders.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Magnolia NeuroSciences
Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Modis Therapeutics
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
Skyhawk Therapeutics
Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.
Swing Therapeutics
Swing Therapeutics provides digital therapeutics for people with chronic conditions.
Synendos Therapeutics
Synendos Therapeutics develops a class of small molecules for the treatment of anxiety and stress-related disorders.
Tellus Therapeutics
Tellus Therapeutics develops novel small molecules derived from human maternal breast milk.
Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
ZetaGen Therapeutics
ZetaGen Therapeutics commercializes a small molecule-based osteoinductive platform.
Current Advisors List
Board_member
2018-09-01
Board_member
Board_member
Current Employees Featured
Tien Lee Founder & CEO @ Aardvark Therapeutics
Founder & CEO
2017-01-01
Dvorit Samid Head of Medical Affairs @ Aardvark Therapeutics
Head of Medical Affairs
2020-01-01
Andreas Niethammer Chief Medical Officer and Co-Founder @ Aardvark Therapeutics
Chief Medical Officer and Co-Founder
2017-05-01
Founder
Investors List
Sorrento Therapeutics
Sorrento Therapeutics investment in Series B - Aardvark Therapeutics
Korea Omega Investment
Korea Omega Investment investment in Series B - Aardvark Therapeutics
Premier Partners
Premier Partners investment in Series B - Aardvark Therapeutics
BNH
BNH investment in Series B - Aardvark Therapeutics
The Foundation for Prader-Willi Research
The Foundation for Prader-Willi Research investment in Series B - Aardvark Therapeutics
Vickers Venture Partners
Vickers Venture Partners investment in Series B - Aardvark Therapeutics
Premier Partners
Premier Partners investment in Series A - Aardvark Therapeutics
Korea Omega Investment
Korea Omega Investment investment in Series A - Aardvark Therapeutics
BNH
BNH investment in Series A - Aardvark Therapeutics
Vickers Venture Partners
Vickers Venture Partners investment in Series A - Aardvark Therapeutics
Official Site Inspections
http://www.aardvarktherapeutics.com Semrush global rank: 5.13 M Semrush visits lastest month: 1.59 K
- Host name: 104.21.48.1
- IP address: 104.21.48.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aardvark Therapeutics"
The Team - Aardvark Therapeutics
As a global, mission-driven Chief Medical Officer and Senior Executive, Dr. Manasi Jaiman advances breakthrough therapies through the integration of medicine and technology drawing …See details»
Aardvark Therapeutics - Crunchbase Company Profile …
Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.See details»
Investor Relations – Aardvark Therapeutics, Inc.
Aardvark Therapeutics, Inc. Investor relations (IR) website contains information about our business for stockholders, potential investors, and financial analysts.See details»
Aardvark Therapeutics - LinkedIn
Aardvark Therapeutics is a clinical-stage biopharmaceutical company developing novel, small-molecule therapies designed to inhibit hunger and transform metabolic healthSee details»
Aardvark Therapeutics (AARD) Company Profile & Description
Feb 13, 2025 Company profile for Aardvark Therapeutics, Inc. (AARD) stock, with a description, list of executives, contact details and other key facts.See details»
AARD - Aardvark Therapeutics Inc. | Company Profile | OTC Markets
Aardvark is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways to alleviate hunger for the …See details»
Aardvark Therapeutics | IPOScoop
Feb 12, 2025 Aardvark TherapeuticsPrintSee details»
AARDVARK THERAPEUTICS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AARDVARK THERAPEUTICS, INC. of San Diego, CA. Get the latest business insights from Dun & …See details»
Aardvark Therapeutics - News, Locations, Executives and …
Usearch discovered 3 locations for Aardvark Therapeutics including locations in San Diego · California. Aardvark Therapeutics is headquartered in 4370 La Jolla Village Dr Ste 1050. The …See details»
Home - Aardvark Therapeutics
Aardvark Therapeutics is a clinical-stage biopharmaceutical company developing novel, small-molecule therapies designed to inhibit hunger and treat metabolicSee details»
Aardvark Therapeutics - VentureRadar
"Aardvark Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of small molecule therapeutics that activate innate …See details»
Aardvark Therapeutics Bolsters Leadership Team with
1 day ago Aardvark Therapeutics Bolsters Leadership Team with Strategic Hires Across Scientific, Commercial, Regulatory and Legal Functions May 19, 2025 16:10 ET | Source: …See details»
Aardvark Therapeutics Bolsters Leadership Team with Strategic …
2 days ago Aardvark is also developing ARD-201, a fixed-dose combination of ARD-101 with a DPP-4 inhibitor, with a goal of addressing some of the limitations of currently marketed GLP-1 …See details»
AARDVARK THERAPEUTICS — Dreavent Capital | Biotech …
Aardvark is a clinical stage biopharmaceutical company focused on the development and commercialization of safe and effective small molecule therapeutics that have broad …See details»
Aardvark Therapeutics Bolsters Leadership Team with Strategic …
1 day ago SAN DIEGO, May 19, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on …See details»
Aardvark Therapeutics. Information about the issuer. . News and …
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of …See details»
Aardvark Therapeutics, Inc., Completes $29M Series B Funding Led …
Aardvark Therapeutics, Inc., Completes $29M Series B Funding Led by Sorrento Therapeutics and Including Existing Investors and the Foundation for Prader-Willi ResearchSee details»
Aardvark Therapeutics, Inc., Completes $29m Series B Funding
Aug 5, 2021 Aardvark Therapeutics, Inc., a clinical stage biopharmaceutical company focused on developing and commercializing novel small molecule therapeutics to activate innate …See details»
News Releases – Aardvark Therapeutics, Inc.
May 7, 2025 View Aardvark Therapeutics, Inc. releases, including company news, investor relations information and more.See details»
Aardvark Therapeutics Bolsters Leadership Team with Strategic …
2 days ago Aardvark Therapeutics Bolsters Leadership Team with Strategic Hires Across Scientific, Commercial, Regulatory and Legal FunctionsSee details»